Loading...

Jingwen Yao, PhD

Title(s)Postdoctoral Scholar, Radiology
SchoolSchool of Medicine
Address1700 4th Street
San Francisco CA 94158
Phone415-502-0646
ORCID ORCID Icon0000-0002-8828-1841 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, Los Angeles, USPhD03/2021Bioengineering
    University of California, Los Angeles, USMS03/2017Biophysics
    Shanghai Jiao Tong Univeristy School of Medicine, ChinaMBBS06/2015Clinical Medicine

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol. 2021 Mar 11. Tatekawa H, Uetani H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. PMID: 33704629.
      View in: PubMed   Mentions:    Fields:    
    2. A physical phantom for amine chemical exchange saturation transfer (CEST) MRI. MAGMA. 2021 Jan 23. Yao J, Wang C, Raymond C, Bergstrom B, Chen X, Das K, Dinh H, Kim ZS, Le AN, Lim MWJ, Pham JAN, Prusan JD, Rao SS, Nathanson DA, Ellingson BM. PMID: 33484366.
      View in: PubMed   Mentions:    Fields:    
    3. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. 2020 Oct 26. Oughourlian TC, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 33106922.
      View in: PubMed   Mentions:    Fields:    
    4. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 10 15; 87(5):931-938. Patel KS, Everson RG, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32365185.
      View in: PubMed   Mentions: 1     Fields:    
    5. Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast. Magn Reson Med. 2021 02; 85(2):1062-1078. Yao J, Wang C, Ellingson BM. PMID: 32936483.
      View in: PubMed   Mentions:    Fields:    
    6. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. J Neurooncol. 2020 Sep; 149(2):337-346. Tatekawa H, Hagiwara A, Uetani H, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32929644.
      View in: PubMed   Mentions:    Fields:    
    7. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 09 09; 10(1):14819. Patel KS, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 32908231.
      View in: PubMed   Mentions:    Fields:    
    8. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Sci Rep. 2020 07 17; 10(1):11922. Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32681084.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. Voxel-Wise and Patient-Wise Correlation of 18F-FDOPA PET, rCBV, and ADC in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. J Nucl Med. 2020 Jul 09. Tatekawa H, Hagiwara A, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32646876.
      View in: PubMed   Mentions: 1     Fields:    
    10. Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma. Clin Cancer Res. 2020 Jul 01; 26(13):3135-3144. Ellingson BM, Yao J, Raymond C, Nathanson DA, Chakhoyan A, Simpson J, Garner JS, Olivero AG, Mueller LU, Rodon J, Gerstner E, Cloughesy TF, Wen PY. PMID: 32269051.
      View in: PubMed   Mentions: 1     Fields:    
    11. Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol. 2020 Mar; 147(1):135-145. Oughourlian TC, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 31981013.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 09 06; 21(9):1184-1196. Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. PMID: 31066901.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    13. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors. Cancer Imaging. 2019 Mar 18; 19(1):14. Chakhoyan A, Raymond C, Chen J, Goldman J, Yao J, Kaprealian TB, Pouratian N, Ellingson BM. PMID: 30885275.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 02 26; 9(1):2846. Chakhoyan A, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 30808879.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):587-595. Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 30806888.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI). Neuroimage Clin. 2019; 22:101736. Ellingson BM, Yao J, Raymond C, Chakhoyan A, Khatibi K, Salamon N, Villablanca JP, Wanner I, Real CR, Laiwalla A, McArthur DL, Monti MM, Hovda DA, Vespa PM. PMID: 30826686.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    17. Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography. 2018 Sep; 4(3):123-137. Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 30320212.
      View in: PubMed   Mentions: 4     Fields:    
    18. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol. 2018 Sep; 139(2):399-409. Patel CB, Fazzari E, Chakhoyan A, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. PMID: 29679199.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    19. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med. 2018 11; 80(5):1962-1978. Harris RJ, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29626359.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    20. Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme. Curr Pharm Des. 2015; 21(36):5256-66. Yao J, Hsu CH, Li Z, Kim TS, Hwang LP, Lin YC, Lin YY. PMID: 26412354.
      View in: PubMed   Mentions:
    Jingwen's Networks
    Concepts (71)
    Derived automatically from this person's publications.
    _
    Co-Authors (15)
    People in Profiles who have published with this person.
    _
    Same Department
    Search Department
    _